Member Info for Elsol

Sorry cannot find this one ?? What is this??

I know we have no RNS clinical data yet but surely all of this give away advertising jobs stuff in the 'public domain' cannot be totally extraneous to our Phase 3 expectations??? RM & Co information releases sort of inside information / insight on the quality of the data or am I barking mad? I did take the top up like many other in last few days but thinking more may be needed tomorrow!

I think that this pesky "virus" and all the "mutants" yet to be born from within our massive global human reservoir (not to mention cross infection and circulation risks to/from pets / farm animals / birds etc) has more "stealth, speed and agility" than man's combined efforts of pharma innovators, healthcare systems and Government in total, so your £1Bn value could easily be very materially understated...just watch and learn my friend over 2022-2025, the virus will be having more fun than you anticipate.

Dear MumboJumbo (apt name!) - you have completely missed the point with a very short sighted comment.... SNG001 is far bigger than any one COVID mutation or another, don't you get it yet? The other broader respiratory infectious disease therapy segments offer a massive market opportunity that dwarfs the current SP. Good luck buddy with your share buying plan! PS I've been in touch with 2 Big pharma colleagues in recent weeks and they tell me there is "watch-list" interest on P3 results, so that may help you in your little investment decision. :-)

Thank you

Maximising the big bang impact. One RNS

My view is that because the INF anti-viral reaction pathway is impaired in Covid 19 infections, then the virus is allowed to "over replicate" and infect a far greater numbers of cells in many organs. Then, the other arsenal of human innate and adaptive immune components go into real over-drive, killing many more infected human cells than necessary and creating severe damage in the worst case in affected organs . I think this is the Long Covid effect. So I do think SNG001 will prevent progress to Long Covid (but not after its happened) and once proven will act as another significant turbo charger to the SNG001 franchise and SP trigger.

Excellent point Tony (assuming SNG001 P3 results are good or stellar). I believe many of us here were quietly thinking the exact same point in the background - SNG001 may prove to have massive "market disruption" potential since a decent proportion of people may not in future want to continue to have vaccine boosters+v4+v5+v6 or even take new variant protection vaccines as long as there is a good safety net reducing threat of severe hospitalised illness & death risk with SNG001. Personal Freedom and feeling of Wellbeing is a vote winner for Governments if they merchandise the concept with their healthcare strategy using our platform technology.

I'll go for £4.75 6pm Monday if RNS lands, once pre orders flow subject to reg. approval it's going above £10 per share.

Docdaneeka - you seem to pounce aggressively to counter my every breath, word and view on this thread. "we won’t need any endorsement from JVT"....utter self serving rubbish! How is that conclusion supportable in any stretch of the imagination given that this stock is so under a bushel that hardly any stock investors in the USA know SNG even exists right now? Rightly or wrongly you are discouraging alternative thinking and possible strategic launch connections on this BB. Your comments about JVT is based on the fact you clearly mistrust or dislike him intensely. Thats it IMV. However, and its a BIG HOWEVER - JVT is already a MASSIVE HOUSEHOLD NAME in infectious diseases in the UK, whether you like him or not so for me if SNG and Soton Univ are surfing his market access waves (using him and his significant market authority) to get their impactful marketing message across to the masses then so be it....watch and maybe learn how this well orchestrated P3/pre-launch announcement may play out. If you were right all the time you would not be on this thread as you would be so rich from trading stocks years ago you would have your feet up drinking G&Ts on your own desert island beach somewhere idyllic.

Monday is "Big Bang" RNS and global breaking news day for SNG001....J Van-Tam on site in Soton Univ as endorsement of the technology advancement and excellent UK scientific breakthrough for improved treatment options for hospitalised patients with severe respiratory viral disease....gives SNG and JVT massive synergistic 'halo' effect to both parties.

Dear Oakleaf - thanks for raising my awareness of this online webinar - I'm now registered - yes very very interesting timing I agree with you. Here is my submitted question below and the same thrust of many messages I sent to UK Government & Kate Bingham Leader of the UK Vaccines Taskforce when Covid all kicked off:

Question submitted to JVT:

Regarding the COVID pandemic, with the benefit of hindsight, does the speaker agree that there is a highly important role for large cohort “Real World Evidence (RWE) studies”, that are rapidly expedited, and volunteer driven, within regulatory ‘lite’ clinical frameworks, to inform evidence of broad efficacy and safety benefits for drug assets in post-phase II (such as Soton Biotech, Synairgen’s SNG001 that exhibited a very clean safety profile and has existing clinical uses in other delivery forms)? This would remove the blockage of elongated and overly onerous regulated clinical trials processes for standard pharma assets, assuming presence of keen volunteers that legally agree to any treatment risk. If not, where would he draw the line of % death rate threshold of any new emerging infection variants, before he would recommend RWE methods as the way forwards to more rapidly introduce effective medicines and perhaps save countless lives globally?

Skippy good responses. Thx

Seems strange to me and maybe others. Must make sense in their portfolio based decisions in the round, but timing of retreat on SNG must be a difficult one for them with all the facts to date. There was a thread by someone here last week saying polar funds had done really badly during 2021 (the entire fund) so they are probably not exposing themselves to say 5% downside risk and giving away 95% chance of value uplift from 205p. Weird.

Big challenge in PMQ time on TV from Labour to boris j & Co. What are they doing about the threat of new variants and also supporting UK Diagnostics supply side...not alot! Labour apparently has been thinking. of course Boris will try to make a super big thing of SNG at readout because he will have to to save face.

RM cant wait too long to release the beans because the CAT is already putting its head through the cat flap! Lots of people and businesses could insider trade now IMO so its got to come soon....this week is my guess (tomorrow?)

Yes the new company web site and the new jobs advertised is the 'leak' pre-RNS....lots of 'smokey' clues in last month, we are just nearing the bend in the road and maybe the 'fire' will be there in all its glory for RM & Co. to extinguish.

Ive just ordered my last glass of vino to toast RM and his team through to victory.

I agree. Intra day is most likely IMV, when US and UK stock markets are open at the same time- why? Because RM has such high integrity and sense of fair play he would not want to prejudice any US based investors without UK trading access who wanted to buy on the P3 news. If it was UK morning then the US investors would miss the boat so to speak on the P3 rise in stock price....it also allows for a joined-up news/social media tsunami that simultaneously hits US and EU together

If as you say P3 results are excellent - you could see the SP double not in the 200s as you say zinc. still below £1bn mkt cap after doubling.